Cencora Inc. (NYSE: COR) signed a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion, the pharmaceutical solutions ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions